San Antonio [US], October 23 (ANI): According to a new study, sexual side effects of cancer therapy are discussed considerably less frequently in female patients than in male patients, even when the medication directly affects genital organs. In a high-volume cancer facility, 9 out of 10 males undergoing brachytherapy for prostate or cervical cancer were asked about their sexual health, compared to 1 out of 10 women.
San Antonio [US], October 23 (ANI): According to a new study, sexual side effects of cancer therapy are discussed considerably less frequently in female patients than in male patients, even when the medication directly affects genital organs. In a high-volume cancer facility, 9 out of 10 males undergoing brachytherapy for prostate or cervical cancer were asked about their sexual health, compared to 1 out of 10 women.
Washington [US], September 15 (ANI): For more than a decade, drugs like enzalutamide, which prevent male hormones from activating the androgen receptor, have been used to treat metastatic prostate cancer. While these treatments are generally effective, they can eventually stop working, but there is little knowledge of how this happens.
Washington [US], May 29 (ANI): A small molecule has been identified that blocks a key pathway in brain tumours, according to the scientists at the University of Michigan Rogel Cancer Center.
Washington [US], May 27 (ANI): According to the scientists at the University of Michigan Rogel Cancer Center, a small molecule has been identified that blocks a key pathway in brain tumours. But there was a problem: How to get the inhibitor through the bloodstream and into the brain to reach the tumour.